SEC 13F Intelligence

GW PHARMACEUTICALS PLC

CUSIP 36197T103

Gw Pharmaceuticals PLC has 283 institutional holders in Filings Flow’s 13F database, together reporting 953.5K shares worth $170.5B as of Q2 2021.

Institutional Holders
283
Q2 2021
Reported Value
$2.7B
Ticker
unmapped
private placement or foreign
Quarters Tracked
5

Ownership Trend

Institutional holders
Q4 ’18: 243Q4 ’18Q1 ’19: 281Q1 ’19Q2 ’19: 283Q2 ’19Q3 ’19: 283Q3 ’19Q2 ’21: 6Q2 ’21filingsflow.com
Total reported value
Q4 ’18: $1.8BQ4 ’18Q1 ’19: $2.8BQ1 ’19Q2 ’19: $3.3BQ2 ’19Q3 ’19: $2.7BQ3 ’19Q2 ’21: $170.5BQ2 ’21filingsflow.com

Holders

Manager% of PortfolioValueSharesQuarter
Strategic Investment Solutions, Inc. /IL$437M AUM0.00%$8,24238Q2 2024
Federation des caisses Desjardins du Quebec$27.8B AUM0.00%$7,86165Q2 2024

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.